Company intelligence / Profile preview

Enceladus Media Group

Amsterdam, North Holland, Netherlandssvs.gsfc.nasa.gov ↗

Ownership: Private
Development stage: Other

Overview

Enceladus Pharmaceuticals develops Nanocort, a targeted liposomal corticosteroid therapy designed to deliver anti-inflammatory drugs directly to diseased sites, aiming for higher efficacy and fewer side effects compared to systemic steroids. The technology is being developed for inflammatory diseases such as rheumatoid arthritis, multiple sclerosis, and certain cancers. Clinical results have not been widely published; the company has focused on prototype therapeutics using previously evaluated drugs combined with novel carrier systems.

Therapeutic areas: OncologyImmunologyNeurology
Modalities: Small moleculeLiposomal drug delivery (lipid vesicle-based therapy)Synthetic glucocorticoid corticosteroid (as part of Nanocort)
Industry: Biotech

Partnerships

Clinquest Group (investment and strategic partnership; Clinquest CEO joined as acting CMO during collaboration)

Beyond the preview

Go deeper on Enceladus Media Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enceladus Media Group.

Explore the full profile